Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sproutly Canada Inc C.SPR

Alternate Symbol(s):  SRUTF

Sproutly Canada, Inc. is a Canada-based company that is a supplier of all-natural water-soluble and oil ingredients for cannabis products for the beverage and consumables market. The Company’s Health Canada Licensed Facility located in the greater Toronto area operates the application (APP) Technology and produces naturally water-soluble cannabis solution (Infuz2O) and cannabis plant oils infused into bio-natural oil (BNO), each delivering the whole plant spectrum of natural bioactive molecules. Infuz2O is a natural water-soluble cannabis solution that can be stably formulated into traditional beverages without the use of artificial chemicals and/or physical means to keep the cannabinoids blended in the water base. It has the licensee of Infusion Biosciences’ APP Technology in Canada, Europe, United Kingdom, Jamaica, Israel, and Australia. BNO is a cannabinoid oils that retain strain-specific attributes, such as euphoria in gorilla glue strains, and relaxation in blueberry strains.


CSE:SPR - Post by User

Bullboard Posts
Comment by SUMKNDV1DERFLon Nov 27, 2019 12:14pm
59 Views
Post# 30398401

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Nice to know...

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Nice to know...
HawkII wrote: Simply delusional. Unfortunately thats very old news as it came out before Q3 results. Take the Canopy comment as an example which assumed $445mm revenue in 2020 going into reporting season ... then they report Q3 results showing significant write-downs, rec revenue -9%, med revenue -36% and Constellation saying they won;t fund them anymore. I haven't checked but I'm guessing that Canaccord anlyst took down his forecasts substantially for Canopy and others.

In addition, since then, (i) vaping news has only gotten worse as reflected in US cannabis company Q3 reporting showing that vape sales have tanked and (ii) the FDA coming out with such harsh language on CBD risks that sector CEO's are also ratcheting down investor expectations as read here

https://www.bnnbloomberg.ca/cbd-forecasts-likely-to-be-slashed-on-fda-warning-analyst-says-1.1353751


Once again, we will have to agree to disagree in regard to your forecasts and rational. As Barstool said, SPR is not into CBD nor are they into vape products. They are focusing on launching THC beverage products. Safe to say that we will have to wait and see how 2020 plays out.  
Bullboard Posts